Just weeks after Australia became the first country to approve the use of MDMA and psilocybin for treating mental health conditions, the decision has drawn sharp criticism from experts and stakeholders. Published interviews and studies have cast doubt over the Therapeutic Goods Administration’s (TGA) move to down-schedule these drugs for clinical use, amid claims 

​   Just weeks after Australia became the first country to approve the use of MDMA and psilocybin for treating mental health conditions, the decision has drawn sharp criticism from experts and stakeholders. Published interviews and studies have cast doubt over the Therapeutic Goods Administration’s (TGA) move to down-schedule these drugs for clinical use, amid claims […] 

​Read More 

Cannabis Law Report